Oragenics Inc (OGEN) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. OGEN - Oragenics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NYSEAM) · Basic Stats · Institutional Ownership and Shareholders · Fund. Overall, Oragenics Inc stock has a Growth Grade of F, Quality Grade of F, Momentum Grade of F. Whether or not you should buy Oragenics Inc stock will. Shares Outstanding M. Price to Sales Ratio 1 Year Return –%. 30 Day Avg Volume 1,, EPS VIEW ALL. About Oragenics Inc. Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases.
About Oragenics (OGEN) ; Avg. daily volume. K ; EBITDA (TTM). -$M ; Open. $ ; Price / earnings ratio. x ; Today's range. $ - $ Oragenics Inc ; Aug PM · Oragenics: Q2 Earnings Snapshot. (Associated Press Finance) +% ; AM · As Traumatic Brain Injuries Increase, Global. Oragenics Inc OGEN:NYSE American · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date01/03/24 · 52 Week Low (NYSE American: OGEN) ("Oragenics" or the "Company") today announced it has extended a licensing and collaboration agreement with the National Research Council. Track Oragenics Inc (OGEN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. Marinus Pharmaceuticals Inc. $ MRNS % ; Smart for Life Inc. $ SMFL % ; Ensysce Biosciences Inc. $ ENSC % ; N2OFF Inc. $ NITO Discover real-time Oragenics Inc. Common Stock (OGEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Information on stock, financials, earnings, subsidiaries, investors, and executives for Oragenics. Use the PitchBook Platform to explore the full profile. Explore the latest news, in-depth analysis, performance evaluation, and Q&A for Oragenics, Inc. (OGEN) stock. Gain valuable insights from earnings call. The current price of OGEN is USD — it has decreased by −% in the past 24 hours. Watch Oragenics Inc. stock price performance more closely on the. Oragenics Inc. (NYSE American: OGEN) is a publicly-traded biopharmaceutical company specializing in innovative, proprietary technologies aimed at improving.
Oragenics Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Find the latest Oragenics, Inc. (OGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. Oragenics Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders. Can Indians buy Oragenics Inc shares? Yes, Indians can invest in the Oragenics Inc (OGEN) from India. With INDmoney, you can buy Oragenics Inc at 0 brokerage. Oragenics Inc. ; Median, $ ; Low, $ ; Average, $ ; Current Price, $ ; Current, -$ Can Indians buy Oragenics Inc shares? Yes, Indians can invest in the Oragenics Inc (OGEN) from India. With INDmoney, you can buy Oragenics Inc at 0 brokerage. The Oragenics Inc stock price today is What Is the Stock Symbol for Oragenics Inc? The stock ticker symbol for Oragenics Inc is OGEN. Is OGEN the Same. The average one-year price target for Oragenics, Inc. is $ The forecasts range from a low of $ to a high of $ Oragenics Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range - 52 Wk Range.
Oragenics (OGEN). , ; BSE Sensex · , ; S&P Small-Cap · , OGEN | Complete Oragenics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Oragenics shares are trading lower by 47% during Wednesday's session. The company announced a $ million public offering. Henry Khederian. Sep 4, On Friday 05/03/ the closing price of the Oragenics Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 05/03/ on BTT of. Company Profile. Logo Oragenics, Inc. Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery.
See charts, data and financials for Oragenics Inc OGEN.